Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case-control study (COVID-19VacRTX)Article Published on 2022-10-062022-11-15 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keac036 PMC 바로가기
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Joint bone spine [Category] [DOI] 10.1016/j.jbspin.2022.105380 PMC 바로가기
Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258Article Published on 2022-10-012022-11-15 Journal: Joint bone spine [Category] [DOI] 10.1016/j.jbspin.2022.105408 PMC 바로가기
An update on the considerations for patients with rheumatic disease being treated with rituximab during the COVID-19 pandemic and the potential drug treatment strategiesReview Published on 2022-10-012023-07-10 Journal: Expert opinion on pharmacotherapy [Category] [DOI] 10.1080/14656566.2022.2131395 PMC 바로가기 [Article Type] Review
Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell LymphomaArticle Published on 2022-09-242022-11-15 Journal: The American journal of case reports [Category] [DOI] 10.12659/AJCR.937500 PMC 바로가기
Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune diseaseArticle Published on 2022-09-142022-11-15 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-022-07722-7 PMC 바로가기
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈Article Published on 2022-09-012022-09-11 Journal: Journal of Intensive Care Medicine [Category] [DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article
Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19오비누투주맙 치료는 오미크론 변이 코로나19로 진단받은 혈액학적 환자에서 더 나쁜 결과를 가져온다Article Published on 2022-09-012022-09-11 Journal: British Journal of Haematology [Category] [DOI] 10.1111/bjh.18315 PMC 바로가기 [Article Type] Article
Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patientsArticle Published on 2022-08-302022-11-15 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-18996-x PMC 바로가기
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyCOVID-19 백신 접종 후 항-CD20 치료 환자의 강력한 T-세포 반응: 전향적 코호트 연구Observational Study Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciab954 PMC 바로가기 [Article Type] Observational Study